Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study
Fig 2
Change of FLS severity (VAS) from before (0 h) to after interferon-ß injection (4 h) (primary endpoint).
Visual analog (VAS) scores were collected at 4 weeks in each treatment sequence. Data shown are total mean VAS scores. ANCOVA analysis was performed on the ITT population (N = 39).